80 related articles for article (PubMed ID: 38672013)
1. Effects of novel beta-lactam, MC-100093, and ceftriaxone on astrocytic glutamate transporters and neuroinflammatory factors in nucleus accumbens of C57BL/6 mice exposed to escalated doses of morphine.
Sari Y; Swiss GMS; Alrashedi FA; Baeshen KA; Alshammari SA; Alsharari SD; Ali N; Alasmari AF; Alhoshani A; Alameen AA; Childers WE; Abou-Gharbia M; Alasmari F
Saudi Pharm J; 2024 Jul; 32(7):102108. PubMed ID: 38868175
[TBL] [Abstract][Full Text] [Related]
2. Cocaine use disorder: A look at metabotropic glutamate receptors and glutamate transporters.
Niedzielska-Andres E; Pomierny-Chamioło L; Andres M; Walczak M; Knackstedt LA; Filip M; Przegaliński E
Pharmacol Ther; 2021 May; 221():107797. PubMed ID: 33359590
[TBL] [Abstract][Full Text] [Related]
3. Effects of Hydrocodone Overdose and Ceftriaxone on Astrocytic Glutamate Transporters and Glutamate Receptors, and Associated Signaling in Nucleus Accumbens as well as Locomotor Activity in C57/BL Mice.
Wong W; Sari Y
Brain Sci; 2024 Apr; 14(4):. PubMed ID: 38672013
[TBL] [Abstract][Full Text] [Related]
4. Effects of ceftriaxone on hydrocodone seeking behavior and glial glutamate transporters in P rats.
Alshehri FS; Hakami AY; Althobaiti YS; Sari Y
Behav Brain Res; 2018 Jul; 347():368-376. PubMed ID: 29604365
[TBL] [Abstract][Full Text] [Related]
5. Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression.
LaCrosse AL; O'Donovan SM; Sepulveda-Orengo MT; McCullumsmith RE; Reissner KJ; Schwendt M; Knackstedt LA
J Neurosci; 2017 Jun; 37(24):5809-5821. PubMed ID: 28495973
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior.
Hammad AM; Alasmari F; Althobaiti YS; Sari Y
Behav Brain Res; 2017 Aug; 332():288-298. PubMed ID: 28624317
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking.
Knackstedt LA; Melendez RI; Kalivas PW
Biol Psychiatry; 2010 Jan; 67(1):81-4. PubMed ID: 19717140
[TBL] [Abstract][Full Text] [Related]
8. Effects of Chronic Hydrocodone Exposure and Ceftriaxone on the Expression of Astrocytic Glutamate Transporters in Mesocorticolimbic Brain Regions of C57/BL Mice.
Wong W; Sari Y
Toxics; 2023 Oct; 11(10):. PubMed ID: 37888720
[TBL] [Abstract][Full Text] [Related]
9. Behavioral sensitization to psychostimulants and opioids: What is known in rodents and what still needs to be explored in humans?
Delage C; Morel A; de Witt P; Jauffret-Roustide M; Bloch V; Noble F; Vorspan F; Marie N
Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110824. PubMed ID: 37479108
[TBL] [Abstract][Full Text] [Related]
10. Effects of a Novel Beta Lactam Compound, MC-100093, on the Expression of Glutamate Transporters/Receptors and Ethanol Drinking Behavior of Alcohol-Preferring Rats.
Alhaddad H; Wong W; Abou-Gharbia M; Childers W; Melenski E; Bell RL; Sari Y
J Pharmacol Exp Ther; 2022 Dec; 383(3):208-216. PubMed ID: 36153003
[TBL] [Abstract][Full Text] [Related]
11. Ceftriaxone as a Novel Therapeutic Agent for Hyperglutamatergic States: Bridging the Gap Between Preclinical Results and Clinical Translation.
Abulseoud OA; Alasmari F; Hussein AM; Sari Y
Front Neurosci; 2022; 16():841036. PubMed ID: 35864981
[TBL] [Abstract][Full Text] [Related]
12. A Novel Morphine Drinking Model of Opioid Dependence in Rats.
Berríos-Cárcamo P; Quezada M; Santapau D; Morales P; Olivares B; Ponce C; Ávila A; De Gregorio C; Ezquer M; Quintanilla ME; Herrera-Marschitz M; Israel Y; Ezquer F
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409269
[TBL] [Abstract][Full Text] [Related]
13. Effects of fentanyl on acute locomotor activity, behavioral sensitization, and contextual reward in female and male rats.
Gaulden AD; Burson N; Sadik N; Ghosh I; Khan SJ; Brummelte S; Kallakuri S; Perrine SA
Drug Alcohol Depend; 2021 Dec; 229(Pt A):109101. PubMed ID: 34628096
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
